Close
Almac
Achema middle east

Press Releases

Global COVID-19 Clinical Trial Tracker Launched by Cytel

Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding...

Sharp Clinical Supports Development of Novel COVID-19 Vaccines and Treatments

Sharp Clinical, part of UDG Healthcare and a leading provider of global clinical supply services, has confirmed that it is involved in supporting six clinical trials related to COVID-19. The company is currently delivering clinical trial packaging, labeling and distribution...

Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility

Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced it has completed an expansion of its biopharmaceutical analysis capabilities at the Durham, North Carolina site. Biopharmaceutical analysis services...

Roche Canada Launches Data Science Coalition to advance COVID-19 solutions

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce the launch of the Roche Data Science Coalition, a group of like-minded public and private organizations committed to working with the global community to develop solutions to the challenges of...

BioLab Sciences to Distribute Rapid Antibody Test for COVID-19

BioLab Sciences, a regenerative biotechnology company, announced they are now distributing tests to detect antibodies specific to 2019n-CoV in humans. The test devices complete the screening using a blood sample from a finger prick and produce results in 10...

CluePoints Launches Complimentary COVID-19 Risk Management Package for Clinical Studies

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, announced that it has launched a complimentary COVID-19 risk management package available to all at no cost. With the FDA, EMA, PMDA...

Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide Therapy for COVID-19 Infection

Mallinckrodt plc , a global biopharmaceutical company, and Novoteris, LLC, a clinical stage medical device and pharmaceutical developer focused on innovative nitric oxide gas applications, announced that the Therapeutic Products Directorate of Health Canada has cleared the companies' joint...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »